About us

We work together with

Founder

Dr. Antonia Gabriel (Fettelschoss)

  • Inventor and founder of Evax AG
  • Studied human biology at the University of Zurich and graduated with a Master of Science degree in 2008. She then started directly with a doctorate in immunology at ETH Zurich and graduated in 2011
  • During her doctorate, she worked part-time at the Clinical Trials Center Zurich and completed internships at the Swiss Institute for Allergy and Asthma (SIAF) and the Swiss Tropical Institute (TPH)
  • Certificate of Advanced Studies in Clinical Trial Management
  • After completing her doctorate, she worked as a scientist at Vifor Pharma and Saiba GmbH.
  • In addition to her work at Evax, she works as a group leader at the University of Zurich / University Hospital Zurich in the field of immunology
  • She started riding at the age of 5 and got to know Icelandic horses at the age of 12 and remains loyal to them to this day. Her family has since owned Icelandic horses, all of which were / are imports from Iceland and were / are affected by sweet itch

Prof. Martin Bachmann

  • Co-inventor and co-founder of Evax AG
  • Founder of Saiba GmbH
  • Autor von mehr als 200 wissenschaftlicher Publikationen.
  • Over 20 years of experience in the field of immunology and more than 10 years of experience in the biotech industry
  • Leading scientist in the field of active immunotherapy for chronic diseases
  • Inventor of over 40 patents in the vaccine field
  • Professor at Oxford, visiting professor at the University of Zurich and Professor of Immunology at the University of Bern

R&D Team

vicy-scaled

Victoria Fettelschoss

Studied biochemistry at the University of Zurich and graduated in 2014.

She is a passionate rider and has been working for Evax AG since 2015.

Victoria is Process and Production Manager and leads clinical vaccine development and production. In addition, she supports current research.

flo-scaled

Florian Olomski

Studied molecular biology at the University of Erlangen and graduated in 2012. He started in Martin Bachmann's research group at the University of Zurich and has been working for Evax AG since 2017.

Florian's main job is basic research and he is our vaccine research and purification specialist. He is also responsible for pre-clinical and assay development

Juwi1-web

Juwela Lam

In 2017 she completed her studies in food sciences and “human health, nutrition and the environment” with a focus on immunology at the ETH Zurich.

Juwela worked for a start-up in the field of immuno-oncology before joining Evax in 2019. She is involved in both preclinical development and the transition to clinical vaccine development and production.

Clinical Team

1

Dr. Sc. ETH Antonia Gabriel (Fettelschoss)

Head of Clinical Studies

02

Dr. Med. Vet. Katharina Birkmann, Dipl. Eceim, EVD

Studied veterinary medicine at the University of Munich and graduated in 2007. Between 2010 and 2014, Katharina made her specialist in internal medicine for horses at the Vetsuisse Faculty of the University of Zurich. She has been working as a veterinarian in the Thurland practice since 2014 and supports the clinical team at Evax AG. She is at our side with all medical questions and supports the health monitoring of the clinical study horses.

saraweb

Sara Straub

Passionate rider and experienced in handling horses. She supports the clinical team part-time.

Tanya-zoom (1)

Tanya Rhiner, Cand. Med. Vet.

Studies veterinary medicine at the Vetsuisse Faculty of the University of Zurich in her last year and is also a passionate rider. She supports the clinical team part-time and has successfully completed her master thesis in our lab.

Advisors

kuendig (1)

Prof. Dr. Med. Thomas M. Kündig

  • Chair of Dermatology and Venereology at the Medical Faculty of the University of Zurich
  • Director of the Dermatological Clinic at the University Hospital Zurich
Christian Surber

Prof. Dr. phil. nat. Christian Surber

  • Professor of Dermatopharmacology and Hospital Pharmacy
  • i.a. expert in drug delivery from topical formulations, topical delivery vehicle design, topical bioavailability / bioequivalence testing, topical pharmacotherapy of barrier function impairment (dry skin, atopic dermatitis, psoriasis) and solar damage (skin cancer)

Grants

EVAX hat Mittel aus Schweizer Stipendien erhalten, darunter die Stiftung Forschung für das Pferd und die Kommission für Technologie und Innovation.